Skip to main content

In like a lion, out like a lamb...

University of Washington genome scientist, Maynard Olson, spoke this weekend at a symposium at Cold Spring Harbor Laboratory in honor of the 60th anniversary of the phage course, where he discussed molecular evolution in chronic bacterial infections. Analysis of whole genome sequences of Pseudomonas aeruginosa, a pathogen responsible for chronic lung colonization in patients with cystic fibrosis, reveals an evolutionary ?weakening? of the bacterium over time, resulting in a much less virulent or

Written byNicole Johnston
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
University of Washington genome scientist, Maynard Olson, spoke this weekend at a symposium at Cold Spring Harbor Laboratory in honor of the 60th anniversary of the phage course, where he discussed molecular evolution in chronic bacterial infections. Analysis of whole genome sequences of Pseudomonas aeruginosa, a pathogen responsible for chronic lung colonization in patients with cystic fibrosis, reveals an evolutionary ?weakening? of the bacterium over time, resulting in a much less virulent organism. Comparing sequences from P. aeruginosa isolates obtained from a patient at 6 months and 96 months of age, with a 97% detection rate, found that 68 mutations had occurred in the late isolate compared to the original wild type. Many mutations were found in virulence genes. One large deletion removed 139 genes. Furthermore, the mutant isolate was sickly and difficult to grow in vitro. ?You overwhelmingly see loss of function mutations,? says Olson. ?There is positive selection to get rid of genes not selected for in the environment.? The findings suggest a microenvironmental heterogeneity, with increasing homogeneity occurring as infection progresses. Several of the genes mutated in this patient were also found to be mutated frequently in other patients as well. Nevertheless, progressive lung destruction continues despite the presence of a less virulent strain. The damage stems from the lungs being caught in the crossfire between infection and host immune responses. These unexpected findings may prove useful for developing novel therapies - desperately needed given high rates of antibiotic resistance among P. aeruginosa. Olson says exploiting new genotypic vulnerabilities in bacteria that are capable of establishing chronic infection may prove highly useful for identifying novel drug targets.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
From Pilot to Practice: Advancing Regulatory Reliance

From Pilot to Precedent: A Year of Regulatory Innovation through PRISM and What it Means for Cloud Adoption in Regulatory Submissions

DNAnexus
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

Illustrated floating metabolites and molecules

Metabolon Verus™ Kit: Metabolomics Profiling Kit

Metabolon
Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics